Table 2

Angiographic and clinical outcomes in patients with AC-LVO treated with DA or SR as first-line device

RefDevice% M1 occlusion% catheter with ID >0.064% with aspiration% with BGCAfter first lineAt the endMedian procedural time (min)% use of rescue therapyComplications% mRS 0–2% mRS 6
% TICI >2b% TICI 3% FPE% TICI >2b% TICI 3ENTsICH
Lapergue
2016
DA71.2%0%100%0%NANANA82.3%*NA4545.2%*5.7%2.4%53.0%22.6%
SR0%0%100%NANANA68.9%*NA5013.5%*6.8%5.9%54.8%17.4%
Lapergue
2017
DA57.1%47.7%100%0%63.0%28.7%NA85.4%37.5%3832.8%5.3%5.3%45.3%19.3%
SR59.1%NA2.9%100%67.7%35.5%NA83.1%38.6%4523.8%8.5%6.5%50.0%19.2%
Stapleton
2018
DA70.2%NA100%0%46.8%NANA83%NA54*42.6%NA12.8%48.9%12.8%
SR61.4%NA55.7%0%NANANA71.4%NA77*NANA10%41.4%18.6%
Benson 2018DA54%NANA25%NANA52%63%35%56.5*22%2%9%39%27%
SR59%NANA72%NANA47%56%29%70*26%2%6%38%26%
Martini
2019
DA72.0%NANANA65.7%NANA91.2%NA28.2*33%*NANANANA
SR72.7%NANANA70%NANA87.5%NA43.8*20.3%*NANANANA
Kang
2019
DANANA100%45.2%55,9%*NA15.4%*80.2%NA60*33.8%*NANA52.0%NA
SRNANA0%61.2%65%*NA35.6%*82.1%NA65*25.5%*NANA55.5%NA
Turk
2019
DA75%98%100%32%83%NANA92%38%25*21%3%6%52%23%
SR7486%85%43%81%NANA89%29%35*NA2%6%50%23%
  • *indicates statistically significant difference.

  • AC-LVO, anterior circulation large vessel occlusion; BGC, balloon guided catheter; DA, distal aspiration; ENT, embolization in new territory; FPE, first pass effect; ID, inner diameter; mRS, modified Rankin scale; NA, not available; sICH, symptomatic intracranial hemorrhage; SR, stent retriever; TICI, Thrombolysis In Cerebral Infarction.